Both in Pharmaceuticals
Revelation Biosciences vs Propanc Biopharma
Over the past year REVB returned −85.8% and PPCB returned −98.9%; their daily moves had a correlation of -0.07.
REVB −85.8% PPCB −98.9%Growth of $1, one year, split-adjusted
| Metric | REVB | PPCB |
|---|---|---|
| Price | $0.8140 | $0.5123 |
| Market cap | $3.2M | $3.2M |
| Today | −5.27% | −3.96% |
| 1 month | −22.5% | −62.1% |
| 6 months | −31.6% | −79.9% |
| Year to date | −74.6% | −96.2% |
| 1 year | −85.8% | −98.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 63.0% | 212.5% |
| Short % of float | 0.0% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).